Open AccessInflammatory Neuropathy Cause and Treatment (INCAT) Scale for the assessment of disability level in patients with chronic inflammatory demyelinating polyneuropathy: linguocultural ratification in Russia
Author(s) -
Anzhelika Arestova,
Evgenia Melnik,
Alexandr Zaytsev,
А. А. Зимин,
Amin Yakubu,
E. S. Sherbakova,
D. G. Yusupova,
Д. А. Гришина,
Н. А. Супонева,
М. А. Piradov
Publication year - 2021
Publication title -
nervno-myšečnye bolezni
Language(s) - English
Resource type - Journals
eISSN - 2413-0443
pISSN - 2222-8721
DOI - 10.17650/2222-8721-2021-11-4-26-33
Subject(s) - chronic inflammatory demyelinating polyneuropathy , medicine , ratification , polyneuropathy , physical therapy , disease , immunology , politics , political science , antibody , law
Background. Chronic inflammatory demyelinating polyneuropathy (CIDP) is a treatable dysimmune polyneuropathy. An objective response for pathogenic therapy is essential in diagnosis and management of CIDP. For proper assessment of patient’s complaints and evaluation of disease progression, it is recommended to use validated scales and questionnaires. The paper presents the results of the first step of Inflammatory Neuropathy Cause and Treatment (INCAT) validation in patients with CIDP. Objective: the development of the Russian version of the INCAT scale and its linguocultural ratification. Materials and methods. 15 patients with definite CIDP (according to EFNS/PNS criteria) were enrolled. Linguocultural ratification was conducted according to the standard protocol. Results. The Russian version of the INCAT scale was developed. Conclusion. We conducted the first stage of INCAT scale validation in patients with CIDP.